Cargando…

Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007

BACKGROUND AND PURPOSE: The reported outcomes of hip resurfacing arthroplasty (HRA) vary. The frequency of this procedure in Denmark, Norway, and Sweden is low. We therefore determined the outcome of HRA in the NARA database, which is common to all 3 countries, and compared it to the outcome of conv...

Descripción completa

Detalles Bibliográficos
Autores principales: Johanson, Per-Erik, Fenstad, Anne Marie, Furnes, Ove, Garellick, Göran, Havelin, Leif I, Overgaard, Sören, Pedersen, Alma B, Kärrholm, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Informa Healthcare 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214740/
https://www.ncbi.nlm.nih.gov/pubmed/20919812
http://dx.doi.org/10.3109/17453674.2010.525193
_version_ 1782216307685457920
author Johanson, Per-Erik
Fenstad, Anne Marie
Furnes, Ove
Garellick, Göran
Havelin, Leif I
Overgaard, Sören
Pedersen, Alma B
Kärrholm, Johan
author_facet Johanson, Per-Erik
Fenstad, Anne Marie
Furnes, Ove
Garellick, Göran
Havelin, Leif I
Overgaard, Sören
Pedersen, Alma B
Kärrholm, Johan
author_sort Johanson, Per-Erik
collection PubMed
description BACKGROUND AND PURPOSE: The reported outcomes of hip resurfacing arthroplasty (HRA) vary. The frequency of this procedure in Denmark, Norway, and Sweden is low. We therefore determined the outcome of HRA in the NARA database, which is common to all 3 countries, and compared it to the outcome of conventional total hip arthroplasty (THA). METHODS: The risk of non-septic revision within 2 years was analyzed in 1,638 HRAs and compared to that for 172,554 conventional total hip arthroplasties (THAs), using Cox regression models. We calculated relative risk (RR) of revision and 95% confidence interval. RESULTS: HRA had an almost 3-fold increased revision risk compared to THA (RR = 2.7, 95% CI: 1.9–3.7). The difference was even greater when HRA was compared to the THA subgroup of cemented THAs (RR = 3.8, CI: 2.7–5.3). For men below 50 years of age, this difference was less pronounced (HRA vs. THA: RR = 1.9, CI: 1.0–3.9; HRA vs. cemented THA: RR = 2.4, CI: 1.1–5.3), but it was even more pronounced in women of the same age group (HRA vs. THA: RR = 4.7, CI: 2.6–8.5; HRA vs. cemented THA: RR = 7.4, CI: 3.7–15). Within the HRA group, risk of non-septic revision was reduced in hospitals performing ≥ 70 HRAs annually (RR = 0.3, CI: 0.1–0.7) and with use of Birmingham hip resurfacing (BHR) rather than the other designs as a group (RR = 0.3, CI: 0.1–0.7). Risk of early revision was also reduced in males (RR = 0.5, CI: 0.2–0.9). The femoral head diameter alone had no statistically significant influence on the early revision rate, but it eliminated the significance of male sex in a combined analysis. INTERPRETATION: In general, our results do not support continued use of hip resurfacing arthroplasty. Men had a lower early revision rate, which was still higher than observed for all-cemented hips. Further follow-up is necessary to determine whether HRA might be useful as an alternative in males.
format Online
Article
Text
id pubmed-3214740
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Informa Healthcare
record_format MEDLINE/PubMed
spelling pubmed-32147402011-11-25 Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007 Johanson, Per-Erik Fenstad, Anne Marie Furnes, Ove Garellick, Göran Havelin, Leif I Overgaard, Sören Pedersen, Alma B Kärrholm, Johan Acta Orthop Research Article BACKGROUND AND PURPOSE: The reported outcomes of hip resurfacing arthroplasty (HRA) vary. The frequency of this procedure in Denmark, Norway, and Sweden is low. We therefore determined the outcome of HRA in the NARA database, which is common to all 3 countries, and compared it to the outcome of conventional total hip arthroplasty (THA). METHODS: The risk of non-septic revision within 2 years was analyzed in 1,638 HRAs and compared to that for 172,554 conventional total hip arthroplasties (THAs), using Cox regression models. We calculated relative risk (RR) of revision and 95% confidence interval. RESULTS: HRA had an almost 3-fold increased revision risk compared to THA (RR = 2.7, 95% CI: 1.9–3.7). The difference was even greater when HRA was compared to the THA subgroup of cemented THAs (RR = 3.8, CI: 2.7–5.3). For men below 50 years of age, this difference was less pronounced (HRA vs. THA: RR = 1.9, CI: 1.0–3.9; HRA vs. cemented THA: RR = 2.4, CI: 1.1–5.3), but it was even more pronounced in women of the same age group (HRA vs. THA: RR = 4.7, CI: 2.6–8.5; HRA vs. cemented THA: RR = 7.4, CI: 3.7–15). Within the HRA group, risk of non-septic revision was reduced in hospitals performing ≥ 70 HRAs annually (RR = 0.3, CI: 0.1–0.7) and with use of Birmingham hip resurfacing (BHR) rather than the other designs as a group (RR = 0.3, CI: 0.1–0.7). Risk of early revision was also reduced in males (RR = 0.5, CI: 0.2–0.9). The femoral head diameter alone had no statistically significant influence on the early revision rate, but it eliminated the significance of male sex in a combined analysis. INTERPRETATION: In general, our results do not support continued use of hip resurfacing arthroplasty. Men had a lower early revision rate, which was still higher than observed for all-cemented hips. Further follow-up is necessary to determine whether HRA might be useful as an alternative in males. Informa Healthcare 2010-10 2010-10-08 /pmc/articles/PMC3214740/ /pubmed/20919812 http://dx.doi.org/10.3109/17453674.2010.525193 Text en Copyright: © Nordic Orthopaedic Federation http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution Noncommercial License which permits any noncommercial use, distribution, and reproduction in any medium, provided the source is credited.
spellingShingle Research Article
Johanson, Per-Erik
Fenstad, Anne Marie
Furnes, Ove
Garellick, Göran
Havelin, Leif I
Overgaard, Sören
Pedersen, Alma B
Kärrholm, Johan
Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007
title Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007
title_full Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007
title_fullStr Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007
title_full_unstemmed Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007
title_short Inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: Evidence from the Nordic Arthroplasty Register Association (NARA) database, 1995 to 2007
title_sort inferior outcome after hip resurfacing arthroplasty than after conventional arthroplasty: evidence from the nordic arthroplasty register association (nara) database, 1995 to 2007
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3214740/
https://www.ncbi.nlm.nih.gov/pubmed/20919812
http://dx.doi.org/10.3109/17453674.2010.525193
work_keys_str_mv AT johansonpererik inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007
AT fenstadannemarie inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007
AT furnesove inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007
AT garellickgoran inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007
AT havelinleifi inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007
AT overgaardsoren inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007
AT pedersenalmab inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007
AT karrholmjohan inferioroutcomeafterhipresurfacingarthroplastythanafterconventionalarthroplastyevidencefromthenordicarthroplastyregisterassociationnaradatabase1995to2007